Impact of healthcare setting on survival in adults with acute lymphoblastic leukemia in Latin America: insights from a large multinational cohort
Survival of adults with ALL in Latin America has improved compared with historical reports, but substantial disparities persist between public and private settings, and upfront dasatinib was associated with improved OS, primarily through lower non-relapse mortality rather than reduced relapse incidence.